Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Quad Technologies Collaborates with University of Massachusetts to Highlight Novel Cell SeparationStudies demonstrate highly viable, pure and completely magnetic bead-free isolated T-Cell populations from human umbilical cord blood samples using MagCloudz™ Cell Separation Kit
By: Quad Technologies The MagCloudz kit enables straightforward, scalable and fast separation of magnetic particle-free cells for applications including T-Cell purification and stem cell isolation, which are critical processing steps in immunotherapy and cell therapy workflows. The results of the study with The University of Massachusetts Medical School demonstrated a successful CD3+/CD45+ T-Cell enrichment from both peripheral and umbilical cord blood samples, with purity of the recovered T-Cell populations exceeding >95%. This high degree of purity, accompanied by high cell viability and the total absence of residual magnetic particles renders the MagCloudz-isolated T-Cells ideal for use in downstream translational applications. Dr Michael Brehm, Associate Professor of Program in Molecular Medicine at the University of Massachusetts Medical School led the study using the MagCloudz kits and discussed the details of the study on a recent webinar supported by Nature entitled ‘Blood Derived T-Cell Enrichment Using a Purification Technology’. The webinar, which also includes an overview of the technology from Sean Kevlahan, CEO of Quad Technologies, can be viewed on demand at www.nature.com. Sean Kevlahan, CEO of Quad Technologies commented "Our collaboration with The University of Massachusetts was a great success and the results clearly demonstrated how our kits truly overcome the limitations of current approaches for cell separation including lengthy protocol times and poor recovery. We have had a great response from our Beta customers to the benefits that MagCloudz delivers and we are looking forward to helping translational research applications improve their cell separation workflow to achieve high quality cells on a scalable and easy to use platform. " Quad has also expanded its offering for the cell isolation workflow to include a magnetic stand that supports the magnetic cell separation steps of the MagCloudz kit workflow. The Q-Mag magnetic stand’s ergonomic design makes it suitable for manual use and enables the easy transport of samples during incubation and vortexing. The stand, which accommodates up to sixteen 1.5-2ml microcentrifuge tubes, is available to purchase at http://quadtechnologies.com/ Quad will be demonstrating the capabilities of the technology on Booth #220 at the Cell & Gene Therapy World Conference taking place from January 25-27, 2016 in Washington, DC. Sean Kevlahan will be delivering a presentation on the capabilities of MagCloudz during the "Technologies of Tomorrow" showcase theater. In 2016, the team at Quad Technologies plans to expand its collaborative reach with new partnerships focused on technology development and refinement for applications critical to regenerative medicine and immunotherapeutic areas. Keep up to date with all the latest news from Quad by following us at @Quad_Tech or join the discussion on LinkedIn. Follow the latest updates from Quad at Cell and Gene Therapy World using the hashtag #QuadCGT. About Quad Technologies Established in 2013, Quad Technologies is a developer of a game changing novel cell separation technology with significant advantages over conventional approaches for the binding and releasing of rare cells from surfaces. With a product driven business model, the company is committed to answering the needs of researchers working in cell separation applications – www.quadtechnologies.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|